Manufacturing Logistics Webinars
-
Innovative Preservation Solutions For Cell Therapy
4/18/2024
The low efficiency and poor biocompatibility of conventional preservatives hinder successful cell preservation. Explore solutions to enhance the stability and post-thaw viability of cell therapy products.
-
Unlocking The Potential Of Your Sterile Injectables With Exact SI-ence
4/16/2024
Sterile injectables present multiple hurdles on the path from early clinical phases to commercial. Learn how a partner with extensive capabilities and expertise can help streamline the path to market.
-
Selecting Container Closure Systems With Confidence: Lyophilization
3/7/2024
Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.
-
End-To-End Cold Chain Management: A Next-Generation Approach
2/26/2024
Three experts in cold chain management walk through the advantages of end-to-end platforms for bulk drug substance management.
-
Cryopreservation Best Practices For Cell & Gene Therapy Source Material
2/26/2024
Industry experts share their experiences, including why and how cellular source materials are cryopreserved and why experience across cell types and methods matters.
-
Key Considerations When Developing Your Combination Product
2/20/2024
Succeed in combination product development by understanding the risk factors that may arise and implementing mitigation strategies that will streamline the device development process.
-
Shelf Lives & Logistics: Ensuring The Stability Of Therapeutic Cancer Vaccines
2/13/2024
In this segment of the Bioprocess Online Live event, guest experts Peter Berglund, chief scientific officer at HDT Bio, Johanna Kaufmann, EVP for oncology at Codagenix, and Robert Georgantas, president and CTO at Providence Therapeutics take audience questions regarding the stability and portability of therapeutic cancer vaccines.
-
Biotech Down Under with BiomeBank's Dr. Sam Costello
12/20/2023
Merry Christmas, Business of Biotechers! On this Christmas Day release, we’re taking a trip to the land down under to visit with Dr. Sam Costello, managing director and co-founder at Adelaide, Australia-based BiomeBank. We covered some ground on this one, most notably the unique path BiomeBank took to chalking up the first donor-derived microbiome therapeutic approval of its kind, anywhere in the world. In a segment of biotech that’s been particularly battered of late, that’s a big, big win.
-
Optimizing mRNA Formulations In A Bottlenecked & Bifurcated Supply Chain
12/5/2023
Combined Therapeutics CSO Thomas Van Cott, Ph.D. and Omega Therapeutics Executive Director, Process Development and Analytical Sciences Jeff Atkinson, Ph.D. address how to overcome the challenge of screening, developing, and optimizing formulations during preclinical development in a fragmented supply chain and outsourced environment.
-
mRNA Therapeutics: To The Liver, And Beyond!
12/5/2023
This segment from the Bioprocess Online Live event, mRNA Update: Beyond Prophylactic Vaccines, introduces guests, Combined Therapeutics CSO Thomas Van Cott, Ph.D. and Omega Therapeutics Executive Director, Process Development and Analytical Sciences Jeff Atkinson, Ph.D., and features Dr. VanCott addressing progress on targets beyond the liver.